Status:
UNKNOWN
Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer
Lead Sponsor:
Hellenic Cooperative Oncology Group
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
EFFECTS OF CYTOTOXIC CHEMOTHERAPY AND PARP INHIBITION ON THE GENOMIC CONTEXTURE OF OVARIAN CANCER: TR\_NACT\_OV/17 In order to approach the above open questions, ultimately aiming in understanding the...
Eligibility Criteria
Inclusion
- ovarian cancer eligible for neoadjuvant chemotherapy
Exclusion
- \-
Key Trial Info
Start Date :
February 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04752865
Start Date
February 9 2018
End Date
June 1 2024
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adamantia Nikolaidi
Athens, Greece, 11524